Stem Cell Authority SCAL Stock
Stem Cell Authority Price Chart
Stem Cell Authority SCAL Financial and Trading Overview
| Stem Cell Authority stock price | 0.0002 USD |
| Previous Close | 0.0003 USD |
| Open | 0.0003 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0003 - 0.0003 USD |
| 52 Week Range | 0.0003 - 0.02 USD |
| Volume | 2.14K USD |
| Avg. Volume | 979 USD |
| Market Cap | 104.61K USD |
| Beta (5Y Monthly) | -45.7169 |
| PE Ratio (TTM) | 0.060000002 |
| EPS (TTM) | 0.005 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SCAL Valuation Measures
| Enterprise Value | 2.28M USD |
| Trailing P/E | 0.060000002 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.03143744 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.686 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stem Cell Authority Stock Price History
| Beta (5Y Monthly) | -45.7169 |
| 52-Week Change | -88.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.0003 USD |
| 50-Day Moving Average | 0.005022 USD |
| 200-Day Moving Average | 0.0068195 USD |
SCAL Share Statistics
| Avg. Volume (3 month) | 979 USD |
| Avg. Daily Volume (10-Days) | 213 USD |
| Shares Outstanding | 348.71M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2009 |
| Most Recent Quarter (mrq) | July 31, 2007 |
| Next Fiscal Year End | August 31, 2010 |
Profitability
| Profit Margin | 55.05% |
| Operating Margin (ttm) | 55.05% |
| Gross Margin | 68.17% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | 49.09% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 3.33M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 2.27M USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | 1.83M USD |
| Diluted EPS (ttm) | 0.005 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 39.84K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 2.22M USD |
| Total Debt/Equity (mrq) | 488.28 USD |
| Current Ratio (mrq) | 1.124 |
| Book Value Per Share (mrq) | 0 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Stem Cell Authority
| Country | United States |
| State | OH |
| City | Fairlawn |
| Address | 123 South Miller Road |
| ZIP | 44333 |
| Phone | 330-835-0200 |
| Website | https://www.stemcellauthority.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child. The company's technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in Fairlawn, Ohio.
Q&A For Stem Cell Authority Stock
What is a current SCAL stock price?
Stem Cell Authority SCAL stock price today per share is 0.0002 USD.
How to purchase Stem Cell Authority stock?
You can buy SCAL shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Stem Cell Authority?
The stock symbol or ticker of Stem Cell Authority is SCAL.
Which industry does the Stem Cell Authority company belong to?
The Stem Cell Authority industry is Medical Care Facilities.
How many shares does Stem Cell Authority have in circulation?
The max supply of Stem Cell Authority shares is 970.85M.
What is Stem Cell Authority Price to Earnings Ratio (PE Ratio)?
Stem Cell Authority PE Ratio is 0.04000000 now.
What was Stem Cell Authority earnings per share over the trailing 12 months (TTM)?
Stem Cell Authority EPS is 0.005 USD over the trailing 12 months.
Which sector does the Stem Cell Authority company belong to?
The Stem Cell Authority sector is Healthcare.